Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Marketing Authorisations (MA) containing Ritalin in Europe. Original Data : EMA Website

Client Email

Product

Ritalin
Dexmethylphenidate
Ritalinic Acid
Methylphenidate
CAS 129389-67-9
CAS 19395-41-6
19395-40-5
CAS 741705-70-4
CAS 20850-49-1
CAS 54631-24-2
Europe

PharmaCompass Sponsored Ads

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

View Presentation

Send me more info on How To Grow My Business Digitally?

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma Corp Ad

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Ritalin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 20 USDMF, 16 CEP/COS, 1 JDMF, 6 EU WC, 8 KDMF, 22 NDC API, 18 Listed Suppliers, $ API Reference Price

36 API Suppliers
20 USDMF
16 CEP/COS
1 JDMF
6 EU WC
8 KDMF
22 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

FINISHED DOSAGE FORMULATIONS

608 FDF Dossiers, 262 FDA Orange Book, 232 Europe, 52 Canada, 30 South Africa, 32 Listed Dossiers

608 FDF Dossiers
262 FDA Orange Book
232 Europe
52 Canada
30 South Africa
32 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 15MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 20MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 30MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 18MG, TABLET, EXTENDED RELEASE;ORAL - 27MG, TABLET, EXTENDED RELEASE;ORAL - 36MG, TABLET, EXTENDED RELEASE;ORAL - 54MG, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, SOLUTION;ORAL - 10MG/5ML, SOLUTION;ORAL - 5MG/5ML, TABLET, CHEWABLE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG
TABLET;ORAL - 20MG
TABLET;ORAL - 5MG
TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML
CAPSULE, EXTENDED RELEASE;ORAL - 10MG
CAPSULE, EXTENDED RELEASE;ORAL - 15MG
CAPSULE, EXTENDED RELEASE;ORAL - 20MG
CAPSULE, EXTENDED RELEASE;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 40MG
CAPSULE, EXTENDED RELEASE;ORAL - 50MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 20MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 30MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 40MG
TABLET, EXTENDED RELEASE;ORAL - 18MG
TABLET, EXTENDED RELEASE;ORAL - 27MG
TABLET, EXTENDED RELEASE;ORAL - 36MG
TABLET, EXTENDED RELEASE;ORAL - 54MG
CAPSULE, EXTENDED RELEASE;ORAL - 10MG
CAPSULE, EXTENDED RELEASE;ORAL - 20MG
CAPSULE, EXTENDED RELEASE;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 40MG
CAPSULE, EXTENDED RELEASE;ORAL - 50MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
SOLUTION;ORAL - 10MG/5ML
SOLUTION;ORAL - 5MG/5ML
TABLET, CHEWABLE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, CHEWABLE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, CHEWABLE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 8 Rochem International Inc, 19 SPI Pharma, 2 Seqens, 18 DKSH, 1 Jai Radhe Sales, 2 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 38 BASF, 1 Bioplus Life Sciences, 20 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 2 Hayashibara, 15 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 39 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 36 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 6 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 3 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

111 Fillers, Diluents & Binders, 84 Coating Systems & Additives, 54 Controlled & Modified Release, 50 Thickeners and Stabilizers, 46 Direct Compression, 37 Taste Masking, 32 Solubilizers, 30 Film Formers & Plasticizers, 30 Granulation, 28 Disintegrants & Superdisintegrants, 27 Topical, 27 Parenteral, 27 Lubricants & Glidants, 22 Chewable & Orodispersible Aids, 18 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 8 API Stability Enhancers, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

111 Fillers, Diluents & Binders
84 Coating Systems & Additives
54 Controlled & Modified Release
50 Thickeners and Stabilizers
46 Direct Compression
37 Taste Masking
32 Solubilizers
30 Film Formers & Plasticizers
30 Granulation
28 Disintegrants & Superdisintegrants
27 Topical
27 Parenteral
27 Lubricants & Glidants
22 Chewable & Orodispersible Aids
18 Co-Processed Excipients
10 Emulsifying Agents
9 Empty Capsules
8 API Stability Enhancers
7 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules
3 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 70 NEWS #PharmaBuzz

5 DATA COMPILATION #PharmaFlow
70 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 150 Finished Drug Prices, 1 Annual Reports

9 US Medicaid Prescriptions
150 Finished Drug Prices
1 Annual Reports

MARKET PLACE

10 APIs, 2 FDF Dossiers

10 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

191 US Patents, 6 US Exclusivities, 25 Health Canada Patents

191 US Patents
6 US Exclusivities
25 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 3 Others

3 EDQM
2 USP
3 Others

$ API Ref.Price (USD/KG) : 783 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

232 All

01 322care4 ApS

02 3Alternova A/S

03 3Cross Pharma AB

04 7InfectoPharm Pharmaceuticals and Consilium GmbH

05 2Janssen Pharmaceutica

06 4Janssen-Cilag AB

07 8Janssen-Cilag AG

08 2Janssen-Cilag AS

09 4Medical Valley Invest AB

10 11Medice Arzneimittel P?tter GmbH & Co KG

11 10Medice Arzneimittel Pütter

12 16Mepha Pharma AG

13 3Mylan AB

14 8Novartis Pharma Schweiz AG

15 16Omnia Läkemedel AB

16 43Orifarm AB

17 3Orifarm AS

18 15Salmon Pharma GmbH

19 4Sandoz - K?benhavn

20 3Sandoz A/S,

21 8Sandoz Pharmaceuticals AG

22 9Shire Pharmaceuticals Ireland

23 6Takeda Pharma AG

24 3Takeda Pharmaceuticals International AG Ireland Branch

25 9Teva B.V.

filter Active Ingredients Reset all filters

232 All

01 109Methylphenidate hydrochloride

02 19methylphenidate hydrochloride

03 104metylfenidathydroklorid

filter Dosage Form Reset all filters

232 All

01 18DEPOTTABLETT

02 8Depocaps

03 19Depot tablet

04 8Depotabs

05 72KAPSEL MED MODIFIERAD FRISÄTTNING, HÅRD

06 15Kaps

07 21Kapsel med modifisert frisetting, hard

08 19PROLONGED-RELEASE TABLET

09 8Ret Tabl

10 6Straight Cap

11 14TABLETT

12 11Tabl

13 13Tablet

filter Country Reset all filters

232 All

01 48Norway

02 123Sweden

03 61Switzerland

filter Brand Name Reset all filters

232 All

01 34Concerta

02 3Equasym

03 31Equasym Depot

04 6Equasym XR

05 61Medikinet

06 9Medikinet MR

07 1Methylphenidat Sandoz

08 8Methylphenidat-Mepha

09 8Methylphenidat-Mepha LA

10 13Methylphenidate 2care4

11 3Methylphenidate Alternova

12 2Methylphenidate Aurora Medical

13 4Methylphenidate Medical Valley

14 3Methylphenidate Mylan

15 14Methylphenidate Sandoz

16 5Methylphenidate Teva

17 4Part moss species

18 14Ritalin

19 6Ritalin LA

20 3Ritalina

Veranova Methylphenidate Hydrochloride

FDF Dossiers
FDA Orange Book
Europe
Canada
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

Janssen-Cilag AB

Pharmaconex 2024

Not Confirmed

Janssen-Cilag AB

Pharmaconex 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

methylphenidate hydrochloride

Brand Name : Concerta

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 27 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Orifarm AB

Pharmaconex 2024

Not Confirmed

Orifarm AB

Pharmaconex 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

methylphenidate hydrochloride

Brand Name : Concerta

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 27 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Orifarm AB

Pharmaconex 2024

Not Confirmed

Orifarm AB

Pharmaconex 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

methylphenidate hydrochloride

Brand Name : Concerta

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 27 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Orifarm AB

Pharmaconex 2024

Not Confirmed

Orifarm AB

Pharmaconex 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

methylphenidate hydrochloride

Brand Name : Concerta

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 18 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Orifarm AB

Pharmaconex 2024

Not Confirmed

Orifarm AB

Pharmaconex 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

methylphenidate hydrochloride

Brand Name : Concerta

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 36 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Orifarm AB

Pharmaconex 2024

Not Confirmed

Orifarm AB

Pharmaconex 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

methylphenidate hydrochloride

Brand Name : Concerta

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 18 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Orifarm AB

Pharmaconex 2024

Not Confirmed

Orifarm AB

Pharmaconex 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

methylphenidate hydrochloride

Brand Name : Concerta

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 36 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Orifarm AB

Pharmaconex 2024

Not Confirmed

Orifarm AB

Pharmaconex 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

methylphenidate hydrochloride

Brand Name : Concerta

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 54 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Orifarm AB

Pharmaconex 2024

Not Confirmed

Orifarm AB

Pharmaconex 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

methylphenidate hydrochloride

Brand Name : Concerta

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 36 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

2care4 ApS

Country

Pharmaconex 2024

Not Confirmed

2care4 ApS

Country

Pharmaconex 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : Sweden

methylphenidate hydrochloride

Brand Name : Concerta

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 27 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?